{"id":"49558301-5893-4431-a587-8a683c199c8f","name":"Medicaroid","slug":"medicaroid","description":"Japanese medical robotics company and joint venture of [Kawasaki Heavy Industries](/companies/kawasaki-heavy-industries) and Sysmex, developing the hinotori™ Surgical Robot System — Japan's first domestically manufactured robotic-assisted surgery platform. Medicaroid obtained Japanese regulatory approval in 2020, received CE mark under MDR in July 2026 for European market entry, and has expanded across Asia-Pacific with approvals in Singapore (2023), Malaysia (2024), and Vietnam (2026). Approximately 20,000 procedures have been performed globally with the hinotori system.","status":"private","founded":2013,"hq":"Kobe, Hyogo Prefecture, Japan","hqLat":34.6932379,"hqLng":135.1943764,"hqGeocodedAt":"2026-08-05T14:38:51.544Z","hqAddress":null,"hqPrecision":null,"website":"medicaroid.com","fundingTotal":null,"type":"hardware","roles":["robot_maker","robot_operator"],"reviewStatus":"reviewed","heatIndex":52,"lifecycleState":"active","supersededByCompanyId":null,"sources":[{"url":"https://medtechdive.com","label":"MedTech Dive"}],"keyFacts":[{"label":"CEO","value":"Koji Muneto (Board Director, CEO and President)"},{"label":"Chairman","value":"Yasuhiko Hashimoto"},{"label":"Parent companies","value":"Kawasaki Heavy Industries + Sysmex (joint venture)"},{"label":"Product","value":"hinotori™ Surgical Robot System"},{"label":"Japan approval","value":"2020 (first domestic manufacturer)"},{"label":"CE mark","value":"July 2026 (under MDR)"},{"label":"Asia-Pacific approvals","value":"Singapore (2023), Malaysia (2024), Vietnam (2026)"},{"label":"Procedures performed","value":"~20,000 globally"},{"label":"Surgical specialties","value":"Urology, general surgery, gynecology, thoracic surgery"},{"label":"Financial stage","value":"Joint venture — funded by Kawasaki Heavy Industries and Sysmex"}],"aliases":[],"collisionRisk":"low","reviewNote":null,"atsProvider":null,"atsSlug":null,"factoryLocations":null,"manufacturingCapacity":null,"orgType":null,"burnSignal":null,"litigationEvents":null,"insurancePostureDisclosed":null,"unitEconomicsDisclosed":null,"tickerSymbol":null,"stockExchange":null,"secCik":null,"revenueUsd":null,"revenueBasis":null,"revenueAsOf":null,"employeeCount":null,"employeeCountBasis":null,"employeeCountAsOf":null,"marketCapUsd":null,"marketCapAsOf":null,"marketCapSource":null,"createdAt":"2026-07-18T12:44:57.298Z","updatedAt":"2026-08-21T22:20:44.309Z","jsonLd":{"@context":"https://schema.org","@type":"Organization","@id":"https://registry.deploy.report/companies/medicaroid","url":"https://registry.deploy.report/companies/medicaroid","name":"Medicaroid","description":"Japanese medical robotics company and joint venture of [Kawasaki Heavy Industries](/companies/kawasaki-heavy-industries) and Sysmex, developing the hinotori™ Surgical Robot System — Japan's first domestically manufactured robotic-assisted surgery platform. Medicaroid obtained Japanese regulatory approval in 2020, received CE mark under MDR in July 2026 for European market entry, and has expanded across Asia-Pacific with approvals in Singapore (2023), Malaysia (2024), and Vietnam (2026). Approximately 20,000 procedures have been performed globally with the hinotori system.","identifier":"49558301-5893-4431-a587-8a683c199c8f","foundingDate":"2013","address":"Kobe, Hyogo Prefecture, Japan","publisher":{"@id":"https://deploy.report/#organization"}},"framework_metadata":{"framework_schema_version":"0.1.0","verification_status":"verified","maturity_stage":null,"lifecycle_state":null,"architectural_position":{"cohort":null,"sub_cohorts":[]},"within_cohort_verified_vs_claimed_pair":null,"cap_flags":[],"verification_depth":{"sources_count":1,"primary_source_types":["secondary-trade-publication"]}}}